These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


395 related items for PubMed ID: 23330407

  • 1. Anderson-Fabry disease: developments in diagnosis and treatment.
    Kes VB, Cesarik M, Zavoreo I, Madzar Z, Demarin V.
    Acta Clin Croat; 2012 Sep; 51(3):411-7. PubMed ID: 23330407
    [Abstract] [Full Text] [Related]

  • 2. [The neurological manifestations of Fabry disease. A review].
    Firsov KV, Kotov AS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016 Sep; 116(9):98-105. PubMed ID: 27735906
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Guidelines for diagnosis, therapy and follow up of Anderson-Fabry disease.
    Kes VB, Cesarik M, Zavoreo I, Soldo-Butković S, Kes P, Basić-Jukić N, Racki S, Jakić M, Delić-Brkljacić D, Jukić Z, Trkanjec Z, Serić V, Solter VV, Bielen I, Basić S, Demarin V, Croatian Society for Neurovascular Disorders of Croatian Medical Association, Croatian Society of Neuroimmunology and Neurogenetics, Croatian Society of Neurology of Croatian Medical Association, Croatian Society of Nephrology, Dialysis and Transplantation of Croatian Medical Association.
    Acta Clin Croat; 2013 Sep; 52(3):395-405. PubMed ID: 24558776
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fabry disease: cardiac manifestations and therapeutic options.
    Pierre-Louis B, Kumar A, Frishman WH.
    Cardiol Rev; 2009 Sep; 17(1):31-5. PubMed ID: 19092368
    [Abstract] [Full Text] [Related]

  • 8. Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells.
    Takenaka T, Murray GJ, Qin G, Quirk JM, Ohshima T, Qasba P, Clark K, Kulkarni AB, Brady RO, Medin JA.
    Proc Natl Acad Sci U S A; 2000 Jun 20; 97(13):7515-20. PubMed ID: 10840053
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Fabry disease].
    Kantola I, Penttinen M, Nuutila P, Viikari J.
    Duodecim; 2012 Jun 20; 128(7):729-39. PubMed ID: 22612023
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fabry disease: treatment and diagnosis.
    Rozenfeld PA.
    IUBMB Life; 2009 Nov 20; 61(11):1043-50. PubMed ID: 19859978
    [Abstract] [Full Text] [Related]

  • 16. Fabry disease.
    Tarabuso AL.
    Skinmed; 2011 Nov 20; 9(3):173-7. PubMed ID: 21675497
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Fabry disease: clinic and enzymatic diagnosis of homozygous and heterozygous. New therapeutic prospects].
    Peces R, Olea T.
    Nefrologia; 2002 Nov 20; 22(6):540-6. PubMed ID: 12516287
    [Abstract] [Full Text] [Related]

  • 19. Cutaneous complications of Anderson-Fabry disease.
    Giuseppe P, Daniele R, Rita BM.
    Curr Pharm Des; 2013 Nov 20; 19(33):6031-6. PubMed ID: 23448454
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.